BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
CYP51
,
G-protein-coupled receptor binding
,
Obesity
,
Pancreas
,
Autoimmunity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Parthenogenetic stem cells
Summary
General Info
Curated Studies
Most Correlated Studies
Parthenogenetic stem cells (PSC), PSC-derived embryoid bodies, and embryonic stem R1 cells
Androgenetic, parthenogenetic and fertilized embryonic stem cells
Pluripotent cells derived by nuclear transfer or by expression of defined factors
Embryonic stem cells - a comparison of cells from parthenogenetic and biparental embryos
Generation of iPS cells from parthenogenetic neural stem cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Alteration of Genomic Imprinting Status of Human Parthenogenetic Induced Pluripotent Stem Cells duri…
Derivation of Mouse Parthenogenetic Advanced Stem Cells.
Uniparental parthenogenetic embryonic stem cell derivatives adaptable for bone and cartilage regener…
Ways Out of the Patenting Prohibition? Human Parthenogenetic and Induced Pluripotent Stem Cells.
SIRT1 regulates autophagy and diploidization in parthenogenetic haploid embryonic stem cells.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study to Evaluate the Safety of Neural Stem Cells in Patients With Parkinson's Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ